New clinical trial for patients exposed to Asbestos

Patients of a hard-to-treat cancer caused by exposure to Asbestos poisoning are being given fresh hope thanks to a new clinical trial.

Researchers from the University of Leicester are trialling a drug that could boost the body's immune system to fight off mesothelioma.

Medical professionals say the disease, which can be caused by exposure to Asbestos, is on the rise.

Mesothelioma affects thousands already each year and is thought to take many years after exposure before it becomes apparent.

  • Each year around 2,300 people are diagnosed in the UK

  • Affects thin membrane that lines the chest and abdomen

  • Most common cause is exposure to asbestos

  • Rare and has a poor prognosis because it is complicated to diagnose and treat.

WATCH: Campaigners call for more research in to Asbestos related cancer